Nurosene Health Inc. (MNNDF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to Nurosene Health Inc. (MNNDF) stock?
Nurosene Health Inc. (MNNDF) no longer trades on public markets. The figures below are historical and are not a current quote.
Market cap $14.3M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Nurosene Health Inc. (MNNDF). Nurosene Health Inc. is a technology-driven wellness company focused on developing and commercializing proprietary nutraceuticals and a virtual care mobile application. Market cap: $14.3M, Sector: Healthcare.
Last analyzed: Mar 18, 2026Analyst Coverage for MNNDF: MNNDF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MNNDF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
MNNDF: 1/2 scored disciplines lean bullish. Dominant signal: Jim Simons bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Nurosene Health Inc. (MNNDF) Healthcare & Pipeline Overview
Nurosene Health Inc. develops nutraceuticals and a virtual care mobile application, targeting the Canadian wellness market with products like Nuro Drive and Nuro Restore. The company aims to improve cognitive function, sleep, and mental health through technology-driven solutions, positioning itself within the competitive healthcare information services sector.
What Is the Investment Thesis for MNNDF?
Nurosene Health Inc. presents a speculative investment opportunity within the burgeoning wellness and digital health sectors. The company's focus on nutraceuticals and a virtual care mobile application positions it to capitalize on the increasing consumer interest in holistic health solutions. Key value drivers include the successful commercialization of Nuro Drive and Nuro Restore, as well as the adoption rate of its virtual care platform. A successful launch and market penetration could drive revenue growth. However, the company faces risks associated with regulatory approvals, competition from established players, and the need for significant capital investment to scale its operations. The company's small market capitalization of $14.3M reflects its early stage and inherent risks. Investors should closely monitor the company's ability to execute its product development and marketing strategies, as well as its financial performance, to assess the viability of this investment.
Based on FMP financials and quantitative analysis
MNNDF Key Highlights
Nurosene Health Inc. is focused on the development of nutraceuticals and a virtual care mobile application.
- The company's key products include Nuro Drive for energy enhancement and Nuro Restore for sleep and stress reduction.
- Nurosene's virtual care mobile application aims to provide continuous support for mental health issues.
- The company was incorporated in 2019 and is headquartered in Toronto, Canada.
- Nurosene Health Inc. has a market capitalization of $14.3M.
Who Are MNNDF's Competitors?
MNNDF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CDXFF Cloud DX Inc. | $0.09 | +12.50% | $9.75M | — |
| NEGXF NexgenRx Inc. | $0.48 | +47.69% | $34.1M | — |
| NOXOF Noxopharm Limited | $0.04 | 0.00% | $14.8M | — |
| PKANF Simply Better Brands Corp. | $0.21 | -16.39% | $14.8M | — |
| SCNX Scienture Holdings, Inc. | $0.35 | -2.69% | $14.1M | — |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | — |
| BEAT HeartBeam, Inc. | $0.40 | -2.14% | $22.3M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.48 | -1.98% | $8.82M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MNNDF's Key Strengths?
Proprietary nutraceutical formulations.
- Technology-driven approach to wellness.
- Virtual care mobile application offering.
- Focus on the growing market for natural health solutions.
What Are MNNDF's Weaknesses?
Limited operating history.
- Small market capitalization.
- Dependence on successful product development and commercialization.
- Limited brand recognition.
What Could Drive MNNDF Stock Higher?
MNNDF catalyst: Launch of the virtual care mobile application, expected in late 2026, could drive user growth and revenue.
- Continued development and commercialization of new nutraceutical products to expand the product line.
- Strategic partnerships with healthcare providers and wellness centers to expand distribution channels.
What Are the Key Risks for MNNDF?
Regulatory challenges in the nutraceutical and digital health industries could delay product approvals and market access.
- Competition from established players in the wellness and mental health markets could limit market share.
- The company's small market capitalization and limited operating history increase the risk of financial instability.
- Dependence on key personnel, including the CEO, poses a risk to the company's strategic direction and execution.
What Are the Growth Opportunities for MNNDF?
- Expansion of Nutraceutical Product Line: Nurosene has the opportunity to expand its line of nutraceutical products to target additional health and wellness needs. This could include developing formulations for weight management, immune support, or specific cognitive functions. The global nutraceutical market is projected to reach $441.7 billion by 2026, presenting a significant opportunity for Nurosene to capture market share through innovative product development and effective marketing strategies. Success hinges on research and development capabilities and strategic partnerships.
- Virtual Care Platform Adoption: The development and successful launch of Nurosene's virtual care mobile application represents a significant growth opportunity. As the demand for accessible mental health support continues to rise, a user-friendly and effective virtual care platform could attract a large user base. The global virtual care market is expected to reach $30 billion by 2028. Nurosene must prioritize user experience, data security, and integration with other healthcare services to maximize adoption.
- Strategic Partnerships and Collaborations: Nurosene can pursue strategic partnerships with healthcare providers, wellness centers, and corporate wellness programs to expand its reach and distribution channels. Collaborations with research institutions could also accelerate product development and validate the efficacy of its nutraceuticals. These partnerships could provide access to new markets and customer segments, driving revenue growth and brand awareness. Identifying and securing mutually beneficial partnerships is crucial for leveraging this opportunity.
- Geographic Expansion: While currently focused on the Canadian market, Nurosene has the potential to expand its operations to other geographic regions, such as the United States or Europe. This would require adapting its products and marketing strategies to local regulations and consumer preferences. International expansion could significantly increase Nurosene's market size and revenue potential. A phased approach, starting with markets with similar regulatory environments, could mitigate risks.
- Personalized Wellness Solutions: Nurosene can leverage data analytics and AI to personalize its nutraceutical recommendations and virtual care programs. By tailoring its offerings to individual needs and preferences, Nurosene can enhance customer engagement and improve health outcomes. The personalized nutrition market is growing rapidly, driven by advancements in genomics and wearable technology. Investing in data infrastructure and analytics capabilities is essential for capitalizing on this trend.
What Threats Does MNNDF Face?
- Competition from established players.
- Regulatory challenges.
- Changing consumer preferences.
- Economic downturn.
What Are MNNDF's Competitive Advantages?
- Proprietary nutraceutical formulations.
- Technology-driven approach to wellness.
- Virtual care mobile application provides a unique service offering.
- Focus on the growing market for natural and holistic health solutions.
What Does MNNDF Do?
Nurosene Inc., established in 2019 and headquartered in Toronto, Canada, operates as a technology-driven wellness company. It focuses on developing and commercializing a range of proprietary nutraceuticals designed to enhance both physical and cognitive well-being. The company's initial product line includes Nuro Drive, formulated to boost physical and cognitive energy levels, and Nuro Restore, which aims to improve sleep quality while reducing stress, pain, and inflammation. In addition to its nutraceutical offerings, Nurosene is developing a virtual care mobile application. This application is intended to provide continuous support and resources to individuals dealing with mental health challenges, marking the company's expansion into digital health solutions. Nurosene's business model centers around creating and distributing products that cater to the growing demand for accessible and holistic wellness solutions. The company targets consumers seeking natural alternatives to traditional medications and therapies, leveraging technology to deliver personalized and convenient care. By combining nutraceuticals with digital health tools, Nurosene aims to establish a comprehensive wellness ecosystem that addresses various aspects of mental and physical health.
What Products and Services Does MNNDF Offer?
- Develops and markets nutraceutical products.
- Focuses on products that enhance physical and cognitive energy levels.
- Offers products to improve sleep and reduce stress.
- Develops a virtual care mobile application for mental health support.
- Aims to provide continuous support to individuals suffering from mental health issues.
- Combines technology and wellness to create holistic health solutions.
How Does MNNDF Make Money?
- Develops proprietary nutraceutical formulations.
- Sells nutraceuticals directly to consumers and through retail channels.
- Generates revenue through subscriptions and in-app purchases on its virtual care platform.
- Partners with healthcare providers and wellness centers for distribution.
What Industry Does MNNDF Operate In?
Nurosene Health Inc. operates within the healthcare information services industry, which is experiencing growth driven by increasing demand for digital health solutions and personalized wellness products. The market is characterized by intense competition, with numerous companies offering nutraceuticals, virtual care platforms, and mental health support services. Trends include the integration of AI and machine learning to enhance personalized care, the rise of telehealth, and a growing emphasis on preventative health measures. Nurosene's success depends on its ability to differentiate its products and services, establish a strong brand presence, and navigate the evolving regulatory landscape.
Who Are MNNDF's Key Customers?
- Individuals seeking to improve their cognitive function and energy levels.
- People looking for natural solutions to improve sleep and reduce stress.
- Individuals seeking accessible mental health support.
- Healthcare providers and wellness centers offering holistic health solutions.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 46 |
| 2026-08-24 | 46 |
| 2026-08-25 | 46 |
| 2026-08-26 | 46 |
What changed?
The score has stayed at 46.
Over the same 3 days the stock moved +0.0%.
Key Financial Metrics
A current ratio of 0.25 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -122.8%, the inverse of the P/E and a quick read on earnings relative to price.
MNNDF Valuation & Market Position
With a $14.3M market cap, Nurosene Health Inc. sits in the micro-cap segment of the market.
Company Profile
Nurosene Health Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO George Achilleos. MNNDF has traded publicly since 2021.
MNNDF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Proprietary nutraceutical formulations.
- Technology-driven approach to wellness.
- Virtual care mobile application offering.
- Focus on the growing market for natural health solutions.
Bear Case
- Limited operating history.
- Small market capitalization.
- Dependence on successful product development and commercialization.
- Limited brand recognition.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MNNDF Latest News
No recent news available for MNNDF.
Leadership: George Achilleos
CEO
George Achilleos is the CEO of Nurosene Health Inc. His background includes experience in the healthcare and technology sectors, with a focus on developing and commercializing innovative products and services. He has a track record of leading teams and driving growth in early-stage companies. Achilleos' expertise spans strategic planning, product development, and market execution. He is responsible for overseeing all aspects of Nurosene's operations, from product development to sales and marketing.
Track Record: Under George Achilleos' leadership, Nurosene Health Inc. has focused on developing its line of proprietary nutraceuticals and its virtual care mobile application. Key milestones include the launch of Nuro Drive and Nuro Restore, as well as the ongoing development of the virtual care platform. Achilleos has been instrumental in securing partnerships and building a team to execute the company's strategic vision.
MNNDF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Nurosene Health Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements and may be subject to greater price volatility and risk.
- OTC Tier: OTC Other
- Limited financial disclosure due to OTC Other tier status.
- Higher price volatility compared to exchange-listed stocks.
- Lower trading volumes and liquidity.
- Potential for limited regulatory oversight.
- Increased risk of fraud or manipulation.
- Verify the company's financial statements, if available.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Review any available news and press releases about the company.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings involving the company.
- Company's incorporation in Canada.
- Development of proprietary nutraceutical formulations.
- Focus on the growing wellness and digital health markets.
- Presence of a CEO with experience in the healthcare and technology sectors.
What Investors Ask About Nurosene Health Inc. (MNNDF) — Healthcare
What happened to Nurosene Health Inc. (MNNDF) stock?
Nurosene Health Inc. (MNNDF) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy MNNDF shares?
No. MNNDF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for MNNDF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before MNNDF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Nurosene Health Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Nurosene Health Inc. do?
Nurosene Health Inc. is a technology-driven wellness company that develops and commercializes proprietary nutraceuticals and a virtual care mobile application.
What do analysts say about MNNDF stock?
As of March 18, 2026, there is no readily available analyst coverage for MNNDF stock due to its OTC listing and small market capitalization.
What are the main risks for MNNDF?
The main risks for Nurosene Health Inc. include regulatory challenges in the nutraceutical and digital health industries, competition from established players in the wellness market, and the company's small market capitalization and limited operating history. Dependence on key personnel and the need for significant capital investment to scale operations also pose risks.
How does Nurosene Health Inc. plan to navigate the regulatory landscape for its nutraceutical products and virtual care platform?
Nurosene Health Inc. intends to navigate the regulatory landscape by ensuring its nutraceutical products comply with Health Canada's regulations for natural health products.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC market investments carry higher risk than exchange-listed stocks.